Helen Sheldon
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- Angiogenesis and VEGF in Cancer
- RNA Interference and Gene Delivery
Papers in
-
- Angiogenesis and VEGF in Cancer 8
- Extracellular vesicles in disease 3
- Circular RNAs in diseases 2
-
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 4
- Co-authors
- Adrian L. Harris (26 shared papers)Francesca M. Buffa (10 shared papers)Jiannis Ragoussis (4 shared papers)Christos Sotiriou (1 shared paper)John Moore (1 shared paper)Jonathan Gleadle (1 shared paper)Russell Leek (6 shared papers)Carme Camps (1 shared paper)
- Journals
- Cancer Research (3 papers)Oncotarget (3 papers)Clinical Cancer Research (2 papers)Oncogene (2 papers)Angiogenesis (2 papers)
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
Helen Sheldon
32 papers receiving 2.4k citations
Helen Sheldon's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 1.3k
- Molecular Biology 1.7k
- Immunology and Allergy 78
- Oncology 283
- Immunology 226
Countries citing papers authored by Helen Sheldon
This map shows the geographic impact of Helen Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Sheldon more than expected).
Fields of papers citing papers by Helen Sheldon
This network shows the impact of papers produced by Helen Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Sheldon. The network helps show where Helen Sheldon may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Sheldon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer Hit paper breakdown → | 2008 | 543 |
| 2 | 2010 | 331 | |
| 3 | 2011 | 253 | |
| 4 | 2011 | 239 | |
| 5 | 2011 | 188 | |
| 6 | 2019 | 104 | |
| 7 | 2008 | 97 | |
| 8 | 2020 | 91 | |
| 9 | 2011 | 88 | |
| 10 | 2017 | 64 | |
| 11 | 2016 | 61 | |
| 12 | 2009 | 46 | |
| 13 | 2015 | 45 | |
| 14 | 2022 | 38 | |
| 15 | 2009 | 35 | |
| 16 | 2017 | 34 | |
| 17 | 2015 | 31 | |
| 18 | 2015 | 30 | |
| 19 | 2010 | 23 | |
| 20 | 2019 | 18 |
About Helen Sheldon
Helen Sheldon is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Allergy and Cellular and Molecular Neuroscience, having authored 32 papers that have together received 2.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cell Adhesion Molecules Research (4 papers), MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (3 papers), Circular RNAs in diseases (2 papers), Axon Guidance and Neuronal Signaling (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.7k citations), Immunology and Allergy (78 citations), Oncology (283 citations) and Immunology (226 citations). Helen Sheldon has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include Adrian L. Harris, Francesca M. Buffa, Jiannis Ragoussis, Christos Sotiriou, John Moore, Jonathan Gleadle, Russell Leek, Carme Camps, Stefano Colella and Richard C.A. Sainson. Their work appears in journals such as Cancer Research, Oncotarget, Clinical Cancer Research, Oncogene and Angiogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.